Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Gary Mason

3PUBLICATIONS
51CO-AUTHORS
PharmacogenomicsMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 30, 2023
Niraparib with Abiraterone Acetate and Prednisone for Metastatic Castration-Resistant Prostate Cancer: Phase II QUEST Study Results.

Kim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri

|Mar 23, 2023
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.

Kim N Chi, Dana Rathkopf, Matthew R Smith

|May 04, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.

Carol Durno, Ayse Bahar Ercan, Vanessa Bianchi

Pageof 1

Frequent Collaborators

2 joint publications

Kim N Chi

1 joint publications

Eleni Efstathiou

1 joint publications

Gerhardt Attard

1 joint publications

David Olmos

1 joint publications

Ji Youl Lee

1 joint publications

Eric J Small

1 joint publications

Andrea J Pereira de Santana Gomes

1 joint publications

Shahneen Sandhu

1 joint publications

Douglas G McNeel

1 joint publications

Ayse Bahar Ercan

Frequent Collaborators

2 joint publications

Kim N Chi

1 joint publications

Eleni Efstathiou

1 joint publications

Gerhardt Attard

1 joint publications

David Olmos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.2K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.5K
See more related videos

Top Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on : Mar 06, 2018

13.2K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on : Jul 28, 2010

12.5K
See more related videos